A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations
Clinical trial NCT03955913 · COMPLETED
Trial details
- NCT number
- NCT03955913
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-08-01
- Primary completion
- 2022-09-19
- Enrollment
- 3679
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.